Summary of Major Findings
Knowledge, Attitude and Practices Survey to SPTCs and LRN Facilities
Fifty-one SPTCs in 24 states were identified at the time of the survey. Among those, the survey was distributed to 49 centers; contact information was missing for two of the centers. In total, 364 survey responses were received from the SPTC population; 66 were excluded because of incompleteness, leaving 298 responses for analyses. Among SPTC respondents, 69% were women and 52% were aged ≥40 years. Thirty-nine percent of SPTC respondents self-identified as nurses and 22% as physicians. Additional health care professional groups included respiratory therapists, emergency medical technicians, advanced practice providers, laboratory technicians, and others. Sixty-two LRN facilities (the number of facilities capable of testing for Ebola virus at the time of the survey) were identified. Ninety-six survey responses were received from this population; 26 were excluded because of incompleteness, leaving 70 responses included for analyses. Among LRN respondents, 64% were women and 76% were aged ≥40 years. Most LRN respondents (64%) self-identified as "laboratory scientist."
Fifty-four percent of SPTC survey respondents reported willingness to be vaccinated if they were eligible and offered the vaccine at the time of survey administration.** When given the choice to get vaccinated at different time points (i.e., when an EVD case is imported to the United States or when an EVD case is imported to their state), willingness to receive vaccine increased to 81%. When asked whether they believed that ACIP should recommend the vaccine for their population, 53% responded yes, 9% responded no, and 38% were unsure.
Fifty-nine percent of LRN survey respondents reported willingness to be vaccinated if they were eligible and offered the vaccine at the time of survey administration.†† When given the choice to get vaccinated at different time points (i.e., when an EVD case is imported to the United States, or when an EVD case is imported to their state), willingness to receive vaccine increased to 86%. When asked whether they believed that ACIP should recommend the vaccine for their population, 59% responded yes, 9% responded no, and 33% were unsure.
Morbidity and Mortality Weekly Report. 2022;71(8):290-292. © 2022 Centers for Disease Control and Prevention (CDC)
